Stock Analysis on Net

Abbott Laboratories (NYSE:ABT) 

Market Value Added (MVA)

Microsoft Excel

Market value added (MVA) is the difference between a firm fair value and its invested capital. MVA is a measure of the value a company has created in excess of the resources already committed to the enterprise.


MVA

Abbott Laboratories, MVA calculation

US$ in millions

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Fair value of debt1 13,710 14,769 16,313 21,152 23,022
Operating lease liability 1,150 1,194 1,173 1,201 1,143
Market value of common equity 233,995 197,828 185,508 205,957 217,969
Preferred shares, one dollar par value, none issued
Noncontrolling interests in subsidiaries 237 224 219 222 219
Less: Marketable securities 674 709 595 852 696
Market (fair) value of Abbott 248,418 213,306 202,618 227,680 241,657
Less: Invested capital2 60,065 59,651 61,288 62,076 60,387
MVA 188,353 153,655 141,330 165,604 181,270

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Fair value of debt. See details »

2 Invested capital. See details »

Item Description The company
MVA Abbott Laboratories market (fair) value less invested capital. Abbott Laboratories MVA increased from 2022 to 2023 and from 2023 to 2024.

MVA Spread Ratio

Abbott Laboratories, MVA spread ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Market value added (MVA)1 188,353 153,655 141,330 165,604 181,270
Invested capital2 60,065 59,651 61,288 62,076 60,387
Performance Ratio
MVA spread ratio3 313.58% 257.59% 230.60% 266.78% 300.18%
Benchmarks
MVA Spread Ratio, Competitors4
Cigna Group 37.77% 49.48% 36.39% 21.75% 20.67%
CVS Health Corp. -4.26% 8.41% 26.73% 49.51% 20.97%
Elevance Health Inc. 51.49% 105.63% 108.49% 116.25% 72.69%
Intuitive Surgical Inc. 2,431.18% 1,699.53% 1,400.02% 2,002.36% 1,853.43%
Medtronic PLC 74.24% 88.43% 93.80% 163.10% 107.64%
UnitedHealth Group Inc. 159.51% 192.81% 214.27% 265.59% 189.93%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 MVA. See details »

2 Invested capital. See details »

3 2024 Calculation
MVA spread ratio = 100 × MVA ÷ Invested capital
= 100 × 188,353 ÷ 60,065 = 313.58%

4 Click competitor name to see calculations.

Performance ratio Description The company
MVA spread ratio The ratio of MVA to invested capital. It measures the efficiency with which investors’ capital investment has translated into a franchise value and into an aggregate net present value premium. Abbott Laboratories MVA spread ratio improved from 2022 to 2023 and from 2023 to 2024.

MVA Margin

Abbott Laboratories, MVA margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Market value added (MVA)1 188,353 153,655 141,330 165,604 181,270
Net sales 41,950 40,109 43,653 43,075 34,608
Performance Ratio
MVA margin2 448.99% 383.09% 323.76% 384.46% 523.78%
Benchmarks
MVA Margin, Competitors3
Cigna Group 12.53% 21.87% 17.38% 11.43% 12.17%
CVS Health Corp. -1.51% 3.18% 10.28% 22.27% 10.70%
Elevance Health Inc. 22.99% 43.23% 46.56% 54.23% 34.07%
Intuitive Surgical Inc. 2,261.68% 1,695.34% 1,209.45% 1,575.51% 1,900.32%
Medtronic PLC 157.30% 199.61% 205.92% 391.27% 264.99%
UnitedHealth Group Inc. 80.18% 95.85% 109.81% 130.39% 96.88%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 MVA. See details »

2 2024 Calculation
MVA margin = 100 × MVA ÷ Net sales
= 100 × 188,353 ÷ 41,950 = 448.99%

3 Click competitor name to see calculations.

Performance ratio Description The company
MVA margin The ratio of MVA to sales. It measures how efficiently and prodigiously sales translate into franchise value. Abbott Laboratories MVA margin ratio improved from 2022 to 2023 and from 2023 to 2024.